First Report Of Safety, Pk, And Preliminary Antitumor Activity Of The Oral Egfr/Her2 Exon 20 Inhibitor Tak-788 (Ap32788) In Non-Small Cell Lung Cancer (Nsclc).Robert Charles Doebele,Gregory J. Riely,Alexander I. Spira,Leora Horn,Zofia Piotrowska,Daniel Botelho Costa,Joel W. Neal,Steven Zhang,William Reichmann,David Kerstein,Shuanglian Li,Pasi A. JanneJOURNAL OF CLINICAL ONCOLOGY（2018）引用 34|浏览9暂无评分AI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
